company
ALEMBIC
Jurisdiction: US
FDA Warning Letter timeline
V1 scope: FDA Warning Letters only. Additional public-record sources (SEC, CPSC, federal contracts) are on the V2 roadmap and are not surfaced here today.
- fda_approval · anda2026-06-25ALEMBIC — ANDA approval: DAPSONE (unspecified)
- fda_approval · anda2026-06-25ALEMBIC — ANDA approval: OSELTAMIVIR PHOSPHATE (unspecified)
- fda_approval · anda2026-06-11ALEMBIC — ANDA approval: TRETINOIN (unspecified)
Frequently asked questions
- How many FDA warning letters has ALEMBIC received?
- Argus HQ has not recorded an FDA warning letter for ALEMBIC in our current dataset.
- What FDA recalls has ALEMBIC issued?
- Argus HQ has not recorded an FDA recall tied to ALEMBIC in our current dataset.
- Is ALEMBIC FDA compliant?
- Argus HQ is not a compliance rating service. As of this page's last update, our dataset shows 0 warning letters, 0 recalls, and 3 approval records for ALEMBIC. Review the linked FDA source records directly before drawing a compliance conclusion.
Informational only. FDA Warning Letters are public records (17 USC §105). Summaries are AI-assisted and may contain errors; always verify against the original FDA letter before acting. Not legal, financial, or regulatory advice.

